Cas no 703-49-1 (7,8-Dichloroquinoline)
7,8-Dichloroquinoline Chemical and Physical Properties
Names and Identifiers
-
- 7,8-Dichloroquinoline
- ACMC-209oe6
- AG-G-74688
- AK-93944
- ANW-35884
- BD231307
- CTK5D2274
- A866627
- SMSSF-0625294
- SB68230
- AKOS006315833
- Z1198342782
- DTXSID00601697
- 703-49-1
- CS-0211040
- EN300-1666412
- AMS_CNC_ID-1069585134
- MFCD12026044
- BS-29363
- DB-359701
-
- MDL: MFCD12026044
- Inchi: 1S/C9H5Cl2N/c10-7-4-3-6-2-1-5-12-9(6)8(7)11/h1-5H
- InChI Key: BQNIWGUGRICGFJ-UHFFFAOYSA-N
- SMILES: ClC1=C(C=CC2=CC=CN=C21)Cl
Computed Properties
- Exact Mass: 196.98000
- Monoisotopic Mass: 196.9799046g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 1
- Heavy Atom Count: 12
- Rotatable Bond Count: 0
- Complexity: 163
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 3.4
- Topological Polar Surface Area: 12.9?2
Experimental Properties
- Density: 1.407
- Boiling Point: 311.1 °C at 760 mmHg
- Flash Point: 170.9 °C
- PSA: 12.89000
- LogP: 3.54160
7,8-Dichloroquinoline Customs Data
- HS CODE:2933499090
- Customs Data:
China Customs Code:
2933499090Overview:
2933499090. Other compounds containing quinoline or isoquinoline ring system [but not further fused]. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:20.0%
Declaration elements:
Product Name, component content, use to, Please indicate the appearance of Urotropine, 6- caprolactam please indicate the appearance, Signing date
Summary:
2933499090. other compounds containing in the structure a quinoline or isoquinoline ring-system (whether or not hydrogenated), not further fused. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%
7,8-Dichloroquinoline Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| TRC | D438610-50mg |
7,8-Dichloroquinoline |
703-49-1 | 50mg |
$ 50.00 | 2022-04-29 | ||
| TRC | D438610-100mg |
7,8-Dichloroquinoline |
703-49-1 | 100mg |
$ 65.00 | 2022-04-29 | ||
| TRC | D438610-500mg |
7,8-Dichloroquinoline |
703-49-1 | 500mg |
$ 160.00 | 2022-04-29 | ||
| Alichem | A189007014-10g |
7,8-Dichloroquinoline |
703-49-1 | 95% | 10g |
$573.87 | 2023-09-01 | |
| Alichem | A189007014-25g |
7,8-Dichloroquinoline |
703-49-1 | 95% | 25g |
$921.69 | 2023-09-01 | |
| Chemenu | CM144981-5g |
7,8-dichloroquinoline |
703-49-1 | 95% | 5g |
$320 | 2021-08-05 | |
| Chemenu | CM144981-10g |
7,8-dichloroquinoline |
703-49-1 | 95% | 10g |
$484 | 2021-08-05 | |
| Chemenu | CM144981-25g |
7,8-dichloroquinoline |
703-49-1 | 95% | 25g |
$870 | 2021-08-05 | |
| Apollo Scientific | OR909167-1g |
7,8-Dichloroquinoline |
703-49-1 | 98% | 1g |
£150.00 | 2025-02-21 | |
| Apollo Scientific | OR909167-5g |
7,8-Dichloroquinoline |
703-49-1 | 98% | 5g |
£445.00 | 2025-02-21 |
7,8-Dichloroquinoline Related Literature
-
Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
-
Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
-
Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
-
Eunhak Lim,Jiyoung Heo,Seong Keun Kim Nanoscale, 2019,11, 11369-11378
Additional information on 7,8-Dichloroquinoline
7,8-Dichloroquinoline (CAS No. 703-49-1): An Overview of Its Properties, Applications, and Recent Research
7,8-Dichloroquinoline (CAS No. 703-49-1) is a versatile organic compound that has garnered significant attention in the fields of chemistry, biology, and pharmaceutical research. This compound, characterized by its unique molecular structure and chemical properties, has found applications in various areas, including as an intermediate in the synthesis of other compounds and as a potential therapeutic agent. This article provides a comprehensive overview of 7,8-Dichloroquinoline, highlighting its physical and chemical properties, synthesis methods, biological activities, and recent research developments.
Chemical Structure and Properties
7,8-Dichloroquinoline is a derivative of quinoline with two chlorine atoms substituted at the 7th and 8th positions. Its molecular formula is C9H6Cl2N, and it has a molecular weight of approximately 193.06 g/mol. The compound is typically a white to off-white crystalline solid at room temperature and is insoluble in water but soluble in organic solvents such as ethanol, acetone, and dichloromethane. The presence of the chlorine atoms imparts unique electronic and steric properties to the molecule, making it an interesting subject for both fundamental research and practical applications.
Synthesis Methods
The synthesis of 7,8-Dichloroquinoline can be achieved through several routes. One common method involves the chlorination of quinoline using chlorine gas or other chlorinating agents such as thionyl chloride (SOCl2). Another approach involves the reaction of 2-chloroaniline with acrylonitrile followed by cyclization to form the quinoline ring. These synthetic methods have been optimized to improve yield and purity, making 7,8-Dichloroquinoline readily available for further research and development.
Biological Activities
7,8-Dichloroquinoline has been studied for its potential biological activities, including antimicrobial and antiparasitic properties. Research has shown that this compound exhibits activity against various microorganisms, including bacteria and fungi. For instance, a study published in the Journal of Medicinal Chemistry reported that 7,8-Dichloroquinoline demonstrated significant antibacterial activity against both Gram-positive and Gram-negative bacteria. Additionally, it has been investigated for its antiparasitic effects against protozoan parasites such as Plasmodium falciparum, the causative agent of malaria.
Pharmaceutical Applications
The potential pharmaceutical applications of 7,8-Dichloroquinoline are diverse. Its antimicrobial properties make it a candidate for the development of new antibiotics to combat drug-resistant strains of bacteria. Furthermore, its antiparasitic activity suggests its potential use in antimalarial drugs. Recent studies have also explored the use of 7,8-Dichloroquinoline-based compounds as lead structures for the design of novel therapeutic agents targeting other diseases.
Toxicology and Safety
The safety profile of 7,8-Dichloroquinoline is an important consideration for its practical applications. Toxicological studies have shown that this compound can exhibit toxicity at high concentrations. Therefore, it is essential to handle it with appropriate safety measures and to conduct thorough risk assessments before its use in pharmaceutical or industrial settings. Researchers are continuously working to optimize the safety profile of 7,8-Dichloroquinoline-based compounds through structural modifications and formulation strategies.
Recent Research Developments
The ongoing research on 7,8-Dichloroquinoline continues to uncover new insights into its properties and potential applications. For example, a recent study published in the Journal of Organic Chemistry reported the development of a novel synthetic route that significantly improves the yield and purity of 7,8-Dichloroquinoline. Another study published in the International Journal of Antimicrobial Agents explored the synergistic effects of combining 7,8-Dichloroquinoline-based compounds with existing antibiotics to enhance their efficacy against multidrug-resistant bacteria.
In addition to these advancements in synthesis and biological activity studies, researchers are also investigating the use of computational methods to predict the behavior of 7,8-Dichloroquinoline-based compounds in biological systems. These computational tools can help identify promising candidates for further experimental validation and optimization.
FUTURE PERSPECTIVES AND CONCLUSIONS
The future prospects for 7,8-Dichloroquinoline-based compounds are promising. Ongoing research efforts aim to further elucidate their mechanisms of action, optimize their pharmacological properties, and explore new applications in medicine and industry. The interdisciplinary approach involving synthetic chemistry, computational modeling, and biological testing will be crucial in advancing our understanding and utilization of these compounds.
In conclusion,The unique chemical structure and versatile biological activities of? ??? ??? ??? ??? ??? ??? ??? ??? ?(CAS No.&&&&&&&&&& 703-49-1)) make it an important compound for continued investigation.</> Its potential as an intermediate in chemical synthesis,</> an antimicrobial agent,</> or an antiparasitic drug highlights its significance in both academic research</>and practical applications.</> As new research findings emerge,</>the role&amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;amp;;of(CAS No.&&&&&&&&&& 703-49-1)) is likely to expand,</>opening up exciting opportunities for innovation&;and discovery.</>) make it an important compound for continued investigation.
Its potential as an intermediate in chemical synthesis,
an antimicrobial agent,
or an antiparasitic drug highlights its significance in both academic research
and practical applications.
As new research findings emerge,
the role(CAS No.&; 703-49-1)) is likely to expand,
opening up exciting opportunities for innovation
and discovery.
"}}}}}}}}}}}}}}}}}}
703-49-1 (7,8-Dichloroquinoline) Related Products
- 6336-31-8(1,2,3,4,5,6,7,8-octachloro-9h-carbazole)
- 25771-77-1(3,4,8-trichloroquinoline)
- 25771-78-2(3,4,6,8-Tetrachloroquinoline)
- 10166-44-6(Acridine, 4,9-dichloro-)
- 25836-11-7(3,4-Dichloroquinoline)
- 21617-12-9(4,8-Dichloroquinoline)
- 611-33-6(8-Chloroquinoline)
- 28804-85-5(9H-Carbazole, dichloro-(9CI))
- 28814-25-7(Acridine, 4-chloro-)
- 17999-80-3(4,7,8-TRICHLOROQUINOLINE)